Curcumin inhibits hypoxia-induced migration in K1 papillary thyroid cancer cells

Exp Biol Med (Maywood). 2015 Jul;240(7):925-35. doi: 10.1177/1535370214555665. Epub 2014 Oct 27.

Abstract

Curcumin, traditionally used as food and medicinal purposes, has recently been reported to have protective efficacy against hypoxia. Hypoxia is one of the important reactive factors in tumor metastasis, which is a key problem in clinical thyroid cancer therapy. In present study, we investigate the anti-metastatic effect of curcumin on the K1 papillary thyroid cancer cells as well as its potential mechanisms. The results show that curcumin effectively inhibits hypoxia-induced reactive oxygen species (ROS) upregulation and significantly decreases the mRNA and protein expression levels of hypoxia-inducible factor-1α (HIF-1α) in K1 cells. Curcumin also decreases the DNA binding ability of HIF-1α to hypoxia response element (HRE). Furthermore, curcumin enhances E-cadherin expression, inhibits metalloproteinase-9 (MMP-9) enzyme activity, and weakens K1 cells migration under hypoxic conditions. In summary, these results indicate that curcumin possesses a potent anti-metastatic effect and might be an effective tumoristatic agent for the treatment of aggressive papillary thyroid cancers.

Keywords: Curcumin; K1 papillary thyroid cancer cell; hypoxia-inducible factor-1α; metastasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Blotting, Western
  • Carcinoma / pathology*
  • Carcinoma, Papillary
  • Cell Hypoxia / drug effects
  • Cell Line, Tumor
  • Cell Movement / drug effects*
  • Curcumin / pharmacology*
  • Electrophoretic Mobility Shift Assay
  • Humans
  • Neoplasm Invasiveness / pathology*
  • Reactive Oxygen Species / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms / pathology*

Substances

  • Antineoplastic Agents
  • Reactive Oxygen Species
  • Curcumin